These benefits, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the concept of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders. So, ahead of investing in this https://erwinm691zyt3.wikimidpoint.com/user